Podcast Episodes
Back to SearchWhy Western pharma is sleeping on China's circular RNA revolution
Episode 209
RNA therapeutics has had its defining moments. Antisense oligonucleotides. siRNA. And then, of course, mRNA — which went from a niche academic curios…
2 months, 1 week ago
Gain Therapeutics: a first-in-class, disease-modifying therapy for Parkinson's
Episode 208
Today we welcome Gene Mack, President and CEO of Gain Therapeutics.
With over 25 years of experience spanning biochemistry, Wall Street analysis, and…
2 months, 2 weeks ago
This nonprofit is building the ecosystem to cure epidermolysis bullosa
Episode 207
Epidermolysis bullosa, or EB, is one of those diseases that stops you in your tracks the moment you understand it. Skin so fragile that the gentlest …
2 months, 3 weeks ago
How BIO-Europe is expanding beyond dealmaking in 2026
Episode 206
The life sciences industry has always had one great meeting place, a few days in November where the deals get done, the partnerships form, and the di…
2 months, 4 weeks ago
Turning cancer cell dependencies into targeted therapies
Episode 205
Today I’m delighted to welcome Andy Parker, CEO of Step Pharma.
With over 25 years of experience across AstraZeneca, Shire, Zealand Pharma, and
venture…
3 months ago
The first PROTAC is here. What comes next in protein degradation?
Episode 204
Today I'm sitting down with Randy Teel, Ph.D., President and CEO of Arvinas, a clinical-stage biotech based in New Haven, Connecticut, that is doing …
3 months, 1 week ago
De-risking neurology drug development with better mouse models
Episode 203
Today we welcome Brandy Wilkinson, CEO of GemPharmatech, and Rikki Feng, the company’s Neuroscience Pipeline Leader.
Our discussion focuses on a pers…
3 months, 2 weeks ago
BIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthaler
Episode 202
This week we preview the BIO International Convention, starting next week in San Diego. This is the key partnering event of the year where biotechs c…
3 months, 3 weeks ago
Advancing corticosteroids and hormonal therapies for supply and scale
Episode 201
Today we’re diving into the world of corticosteroids and hormonal therapies — essential APIs that treat everything from asthma and autoimmune disease…
4 months ago
Episode 200 Special: Joachim Eeckhout on building Labiotech and the future of biotech media
Episode 200
Welcome to episode 200!
Today I’m delighted to welcome back a very special guest: Joachim Eeckhout, the co-founder of Labiotech, co-owner of Knowbio, …
4 months, 1 week ago